20.10
price down icon2.80%   -0.58
after-market Handel nachbörslich: 20.11 0.010 +0.05%
loading
Schlusskurs vom Vortag:
$20.68
Offen:
$20.53
24-Stunden-Volumen:
308.44K
Relative Volume:
0.67
Marktkapitalisierung:
$1.19B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-85.21M
KGV:
-10.63
EPS:
-1.89
Netto-Cashflow:
$-68.53M
1W Leistung:
-0.05%
1M Leistung:
+0.70%
6M Leistung:
+16.93%
1J Leistung:
-27.57%
1-Tages-Spanne:
Value
$19.98
$20.53
1-Wochen-Bereich:
Value
$19.98
$21.81
52-Wochen-Spanne:
Value
$13.30
$30.03

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
Firmenname
Enliven Therapeutics Inc
Name
Telefon
720-647-8519
Name
Adresse
6200 LOOKOUT ROAD, BOULDER
Name
Mitarbeiter
63
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ELVN's Discussions on Twitter

Vergleichen Sie ELVN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ELVN
Enliven Therapeutics Inc
20.10 1.22B 0 -85.21M -68.53M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-16 Eingeleitet Goldman Buy
2024-12-13 Eingeleitet BTIG Research Buy
2024-09-09 Eingeleitet H.C. Wainwright Buy
2024-06-11 Eingeleitet Robert W. Baird Outperform
2024-04-09 Eingeleitet Mizuho Buy
2023-03-29 Eingeleitet Jefferies Buy
Alle ansehen

Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten

pulisher
12:01 PM

Enliven Therapeutics Inc. recovery potential after sell offBuy Signal & Safe Capital Growth Plans - newser.com

12:01 PM
pulisher
06:45 AM

What the charts say about Enliven Therapeutics Inc. todayShort Setup & Daily Volume Surge Trade Alerts - newser.com

06:45 AM
pulisher
02:44 AM

How to read the order book for Enliven Therapeutics Inc.July 2025 Setups & AI Forecast Swing Trade Picks - newser.com

02:44 AM
pulisher
02:33 AM

Strategies to average down on Enliven Therapeutics Inc.July 2025 Patterns & Expert Curated Trade Setups - newser.com

02:33 AM
pulisher
Oct 13, 2025

Heatmap analysis for Enliven Therapeutics Inc. and competitorsJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Automated trading signals detected on Enliven Therapeutics Inc.Trade Exit Summary & Consistent Return Investment Signals - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Chart based exit strategy for Enliven Therapeutics Inc.July 2025 Fed Impact & Daily Stock Trend Reports - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Enliven Therapeutics (NASDAQ:ELVN) Trading 6.1% HigherHere's Why - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,667 Shares of Stock - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Volatility clustering patterns for Enliven Therapeutics Inc.Rate Cut & Free Weekly Watchlist of Top Performers - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is a relief rally coming for Enliven Therapeutics Inc. holdersWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Long term hold vs stop loss in Enliven Therapeutics Inc.2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Enliven Therapeutics (NASDAQ:ELVN) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Using Ichimoku Cloud for Enliven Therapeutics Inc. technicals2025 Analyst Calls & Consistent Growth Equity Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Enliven Therapeutics COO Patel sells $133,992 in stock By Investing.com - Investing.com South Africa

Oct 09, 2025
pulisher
Oct 09, 2025

Enliven Therapeutics COO Patel sells $133,992 in stock - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Short interest data insights for Enliven Therapeutics Inc.Market Activity Report & Real-Time Volume Spike Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What moving averages say about Enliven Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why retail investors favor Enliven Therapeutics Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is now a turning point for Enliven Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Enliven Therapeutics stock falls after pricing capital raise of $200M via securities offering - MSN

Oct 08, 2025
pulisher
Oct 06, 2025

Developing predictive dashboards with Enliven Therapeutics Inc. dataStop Loss & Weekly Sector Rotation Insights - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Will Enliven Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Top chart patterns to watch in Enliven Therapeutics Inc.July 2025 Retail & Risk Managed Investment Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Enliven Therapeutics Inc. stock recover after recent drop2025 Earnings Impact & Precise Swing Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

Benjamin Hohl Sells 3,250 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $81,000.00 in Stock - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Enliven Therapeutics CFO sells $22,524 in stock - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Enliven Therapeutics (NASDAQ:ELVN) CEO Samuel Kintz Sells 3,700 Shares - MarketBeat

Sep 30, 2025

Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Enliven Therapeutics Inc-Aktie (ELVN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sep 29 '25
Option Exercise
2.48
3,250
8,060
26,250
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sep 29 '25
Sale
20.40
3,250
66,291
23,000
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sep 26 '25
Sale
20.25
4,000
81,005
927,688
Kintz Samuel
PRESIDENT AND CEO
Sep 26 '25
Sale
20.06
3,700
74,228
915,392
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):